is there a patent on semaglutide As the for semaglutide, the key ingredient in the popular weight-loss drug Ozempic, set to expire in March, Indian pharmaceutical giants are gearing up to flood the market with generic China's weight-loss drug makers take

The stability is validated

Yes, conceptually

The timing aligns with Health Canada's 180-day review timeline for generic drug applications, though complex submissions may require additional processing time

Studies have observed interactions between GLP-1 receptor pathways and the hypothalamic-pituitary-adrenal (HPA) axis, hinting at potential roles in modulating cortisol levels, feeding behavior under stress, and central energy-sensing mechanisms

Semaglutide may have an impact on dopamine levels by helping balance the brains reward system, which plays a key role in obesity

For Obesity: The starting dose is 0.25 mg Semaglo SC Injection 0.25 mg/0.188 ml once weekly for 4 weeks subcutaneously